[Clinical application of sclerosing agent injection in treating habitual dislocation of temporomandibular joint].
Based on the experimental study, small amount of sclerosing agent was injected to the site outside the joint and below the ridge of TMJ on 105 cases for the treatment of habitual dislocation of TMJ. All of the cases were followed-up for more than 2 years and it was found that the cure rate reached 89 percent, including one case who was followed-up for 19 years free from recurrence. This method is suggested as it is simple to perform and acceptable to the patients. It has to be mentioned, however, that this injection was not so effective for those with cerebrovascular disease associated with habitual dislocation of TMJ.